Immune receptor that's typically activated by bacteria is a major contributor to bladder dysfunction in diabetes

February 06, 2017

AUGUSTA, Ga. (Feb. 6, 2017) - Bladder dysfunction is a reality for about half of patients with diabetes and now scientists have evidence that an immune system receptor that's more typically activated by bacteria is a major contributor.

In the face of diabetes, scientists have shown for the first time that contents released by dying cells activate Toll-like receptor 4, or TLR4, a driver of inflammation, on the muscular bladder wall, resulting in a thicker, less compliant organ that soon struggles to carry out its basic functions of storing and excreting urine, said Dr. Theodora Szasz, postdoctoral fellow in the Department of Physiology at the Medical College of Georgia at Augusta University.

In patients, that eventually translates to having to excrete a greater volume of urine more frequently and ultimately possible incontinence if basic bladder function is lost. Now scientists show in an animal model that preventing activation of TLR4 enables the wall to remain strong but elastic even in the face of high glucose, a diabetes hallmark that also inflames. Szasz, who works in the lab of MCG physiology chairman, Dr. R. Clinton Webb, is corresponding author of the study in the journal Diabetes.

Szasz and her colleagues hope the finding will ultimately lead to treatments that protect the bladder. Immediate future studies include looking specifically at the contribution of glucose and HMGB1, which is released by dying cells, and the effect of inhibiting HMGB1.

The bladder has to be both elastic so it can expand to hold urine, and muscular so it can contract to expel it. Its work is significantly increased in diabetes where patients tend to be thirsty and consume more fluids and kidneys produce more urine in an effort to help clear high levels of glucose in the blood.

High glucose already drives inflammation - likely through some of the same mechanisms and possibly additional pathways as HMGBI - which causes increased cell death in organs and blood vessels throughout the body. As more cells die, they dump their contents, which now look like foreign bacteria or viruses to the immune system. Among those cell contents, now called damage associated molecular patterns, or DAMPs, is HMGB1, which inside the cell helps stabilize DNA, but outside garners the attention of TLR4, one of a family of immune cell receptors that is more typically activated by a membrane component of bacteria.

Patients with diabetes have evidence of increased TLR4 expression in the lining of their bladder and of its activity throughout their body. There is evidence as well of higher levels of HMGB1 and other substances that might bind with Toll-like receptors. There's additional evidence that in diabetes, HMGB1 activates TLR4 as does high glucose.

The MCG team appears to be the first to document the destructive activation in an animal model of diabetes-related bladder dysfunction, including downstream effects such as increased production of immune cells called cytokines that promote inflammation, increased reactive oxygen species production and other changes that are known to, in turn, impact muscle contraction. The scenario correlates with usual clinical progression of the condition, Szasz said.

The blood of their mouse model of diabetes expressed more HMGB1 than normal mice and the muscular bladder wall - on which these studies focused - expressed more of both TLR4 and its downstream molecule MYD88, which can ultimately influence gene expression as well as cell growth and death. Contraction and bladder weight were also increased in the mouse model of diabetes but a drug that inhibited TLR4 normalized them. While mice missing TLR4 still developed the classic high glucose levels of diabetes, they were protected from thickened bladder walls and excessive contractility, Szasz and team reported.

In the early stages of diabetes, the bladder tries to compensate for the increased volume of urine with a thicker and initially stronger muscle wall. So, while patients may begin to urinate more frequently and a greater volume each time, the bladder can maintain its fundamental functions of storage and expelling. But much like with heart failure, the bladder muscle over time can become big and dysfunctional, not able to contract as well, ultimately failing at both tasks and the patient becomes incontinent.

Like the rest of the body, the bladder gets exposed to high glucose levels from the blood perfusing it, but also from the urine it's storing for removal. While there has long been evidence that these high levels produce changes like increased levels of destructive reactive oxygen species, just what happens to cause dysfunction of the bladder's two primary functions in diabetes has been unknown. Szasz notes that use of antioxidants to slow disease progression have been unsuccessful. There are a wide variety of drugs, even surgery to treat symptoms, such as frequent urination, but not for direct causes of bladder dysfunction, which scientists like Szasz are still helping define. She notes that as with all effects of diabetes, excellent control of blood glucose levels, remains the best option for avoiding complications.

Much like our blood vessels, the exterior of the bladder is essentially a matrix of smooth muscle cells and it's lined with urothelial cells involved in a host of functions, including serving as natural barriers and reacting to stimuli, such as bacteria like E. coli, the most common cause of urinary tract infections. Both the inner and out layer become thicker and less efficient during relatively early stages of diabetic bladder dysfunction.

In a rather vicious cycle, bacteria are attracted to the higher glucose levels in the bladder, so there also are more bladder infections, which also activate Toll-like receptors and likely further contribute to the damage, Szasz said.
-end-
The research was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Diabetic Complications Consortium.

Medical College of Georgia at Augusta University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.